|
Section 799.1
|
Applicability |
|
Section 799.2
|
Definitions |
|
Section 799.3
|
Submission of information |
|
Section 799.5
|
Test standards |
|
Section 799.10
|
Availability of test guidelines |
|
Section 799.11
|
Test results |
|
Section 799.12
|
Effects of non-compliance |
|
Section 799.17
|
Chemicals subject of test rules or consent orders for which the |
|
Section 799.18
|
Chemical imports and exports |
|
Section 799.19
|
Trichlorobenzenes |
|
Section 799.1053
|
Diethylene glycol butyl ether and diethylene glycol butyl ether |
|
Section 799.1560
|
Diethylenetriamine (DETA) |
|
Section 799.1575
|
Fluoroalkenes |
|
Section 799.1700
|
Commercial hexane |
|
Section 799.2155
|
Isopropanol |
|
Section 799.2325
|
Methyl ethyl ketoxime |
|
Section 799.2700
|
Unsubstituted phenylenediamines |
|
Section 799.3300
|
Tributyl phosphate |
|
Section 799.4360
|
Triethylene glycol monomethyl ether |
|
Section 799.4440
|
Testing consent orders for substances and mixtures with |
|
Section 799.5000
|
Testing consent orders for mixtures without Chemical Abstracts |
|
Section 799.5025
|
Hazardous waste constituents subject to testing |
|
Section 799.5055
|
Drinking water contaminants subject to testing |
|
Section 799.5075
|
Chemical testing requirements for first group of high |
|
Section 799.5085
|
Chemical testing requirements for second group of high |
|
Section 799.5087
|
Chemical testing requirements for third group of high |
|
Section 799.5089
|
Chemical testing requirements for certain chemicals of interest |
|
Section 799.5115
|
TSCA partition coefficient (n-octanol/water), shake flask |
|
Section 799.6755
|
TSCA partition coefficient (n-octanol/water), generator column |
|
Section 799.6756
|
TSCA water solubility: Column elution method; shake flask |
|
Section 799.6784
|
TSCA water solubility: Generator column method |
|
Section 799.6786
|
TSCA acute oral toxicity |
|
Section 799.9110
|
TSCA acute dermal toxicity |
|
Section 799.9120
|
TSCA acute inhalation toxicity |
|
Section 799.9130
|
TSCA acute inhalation toxicity with histopathology |
|
Section 799.9135
|
TSCA Repeated dose 28-day oral toxicity study in rodents |
|
Section 799.9305
|
TSCA 90-day oral toxicity in rodents |
|
Section 799.9310
|
TSCA 90-day dermal toxicity |
|
Section 799.9325
|
TSCA 90-day inhalation toxicity |
|
Section 799.9346
|
TSCA reproduction/developmental toxicity screening test |
|
Section 799.9355
|
TSCA combined repeated dose toxicity study with the |
|
Section 799.9365
|
TSCA prenatal developmental toxicity |
|
Section 799.9370
|
TSCA reproduction and fertility effects |
|
Section 799.9380
|
TSCA chronic toxicity |
|
Section 799.9410
|
TSCA carcinogenicity |
|
Section 799.9420
|
TSCA combined chronic toxicity/carcinogenicity |
|
Section 799.9430
|
TSCA bacterial reverse mutation test |
|
Section 799.9510
|
TSCA in vitro mammalian cell gene mutation test |
|
Section 799.9530
|
TSCA in vitro mammalian chromosome aberration test |
|
Section 799.9537
|
TSCA mammalian bone marrow chromosomal aberration test |
|
Section 799.9538
|
TSCA mammalian erythrocyte micronucleus test |
|
Section 799.9539
|
TSCA neurotoxicity screening battery |
|
Section 799.9620
|
TSCA developmental neurotoxicity |
|
Section 799.9630
|
TSCA metabolism and pharmacokinetics |
|
Section 799.9748
|
TSCA immunotoxicity |
|
Section 799.9780
|
To whom do these requirements apply? |